HIBCH, 3-hydroxyisobutyryl-CoA hydrolase, 26275

N. diseases: 60; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease CLINGEN 3-Hydroxyisobutyryl-CoA hydrolase deficiency in an Iranian child with novel HIBCH compound heterozygous mutations. 30847210 2019
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease CLINGEN Truncating mutations of HIBCH tend to cause severe phenotypes in cases with HIBCH deficiency: a case report and brief literature review. 29703962 2018
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 GeneticVariation disease CLINVAR Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. 26163321 2015
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease CLINGEN Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. 26163321 2015
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease CLINGEN Successful diagnosis of HIBCH deficiency from exome sequencing and positive retrospective analysis of newborn screening cards in two siblings presenting with Leigh's disease. 26026795 2015
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 GeneticVariation disease BEFREE Only three families with HIBCH deficiency and biallelic HIBCH mutations have been described. 25251209 2014
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease CLINGEN Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis. 27896122 2014
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease CLINGEN HIBCH mutations can cause Leigh-like disease with combined deficiency of multiple mitochondrial respiratory chain enzymes and pyruvate dehydrogenase. 24299452 2013
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease GENOMICS_ENGLAND HIBCH mutations can cause Leigh-like disease with combined deficiency of multiple mitochondrial respiratory chain enzymes and pyruvate dehydrogenase. 24299452 2013
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 GermlineCausalMutation disease ORPHANET HIBCH mutations can cause Leigh-like disease with combined deficiency of multiple mitochondrial respiratory chain enzymes and pyruvate dehydrogenase. 24299452 2013
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 GermlineCausalMutation disease ORPHANET Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase results in progressive infantile neurodegeneration. 17160907 2007
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 GeneticVariation disease UNIPROT Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase results in progressive infantile neurodegeneration. 17160907 2007
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease CLINGEN Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase results in progressive infantile neurodegeneration. 17160907 2007
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 GeneticVariation disease CLINVAR Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase results in progressive infantile neurodegeneration. 17160907 2007
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease GENOMICS_ENGLAND beta-hydroxyisobutyryl coenzyme A deacylase deficiency: a defect in valine metabolism associated with physical malformations. 7122152 1982
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease GENOMICS_ENGLAND
Beta-Hydroxyisobutyryl CoA Deacylase Deficiency
0.710 Biomarker disease CTD_human
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.300 Biomarker disease CTD_human Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. 18784066 2009
CUI: C0086743
Disease: Osteoarthrosis Deformans
Osteoarthrosis Deformans
0.300 Biomarker disease CTD_human Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. 18784066 2009
CUI: C0013421
Disease: Dystonia
Dystonia
0.110 GeneticVariation phenotype BEFREE Here, we report a female Chinese patient presenting with exercise-induced dystonia and bilateral symmetrical hyperintensities of the globus pallidus on brain MRI associated with novel HIBCH mutations (c.1027C>G;p. H343D and c.383T>A;p.V128D). 31679561 2019
CUI: C0013421
Disease: Dystonia
Dystonia
0.110 Biomarker phenotype HPO
CUI: C2985280
Disease: Blood Protein Measurement
Blood Protein Measurement
0.100 GeneticVariation phenotype GWASCAT Co-regulatory networks of human serum proteins link genetics to disease. 30072576 2018
CUI: C0026827
Disease: Muscle hypotonia
Muscle hypotonia
0.100 GeneticVariation phenotype CLINVAR Successful diagnosis of HIBCH deficiency from exome sequencing and positive retrospective analysis of newborn screening cards in two siblings presenting with Leigh's disease. 26026795 2015
CUI: C0026827
Disease: Muscle hypotonia
Muscle hypotonia
0.100 CausalMutation phenotype CLINVAR Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. 26163321 2015